WHO Treatment Changes for Drug-Resistant TB Infections

May 4, 2022 by Alexa Hornbeck
WHO Treatment Changes for Drug-Resistant TB Infections
(Photo by Dan McCue)

The World Health Organization’s Global Tuberculosis Program has informed medical practitioners and other healthcare providers of changes in the treatment of drug-resistant TB.

The updates include trimming the six-month all-oral regimens, and an alternative nine-month all-oral regimen. 

“This is major progress compared to what was available even a few years ago, and will be a great benefit for people struggling with TB and drug-resistant TB, resulting in better outcomes, saving lives and reducing suffering,” said Dr. Tereza Kasaeva, director of the WHO’s Global TB Program, in a written statement

In 2020, an estimated 10 million people developed TB and 1.5 million died from the disease. WHO researchers estimate that, due to the COVID-19 pandemic, TB incidence could increase globally in 2022 and 2023. 

About 500,000 new cases of drug-resistant TB are estimated to emerge each year, but only one in three cases were reported to have been treated, according to the rapid communication.

Some new regimens that have not yet been appraised by the WHO have been tested in trials, such as the new six-month regimen of bedaquiline, pretomanid and linezolid in combination with moxifloxacin, evaluated in the TB-PRACTECAL randomized clinical trial.

The WHO launched the rapid communication ahead of its consolidated guidelines, which are expected later in 2022. 

Alexa can be reached at [email protected]

A+
a-

In The News

Health

Voting

Health

March 27, 2024
by Dan McCue
One-Time Treatment Could Revitalize Immune Systems in the Elderly

PALO ALTO, Calif. — A new study suggests that a one-time treatment that modulates the composition of a type of... Read More

PALO ALTO, Calif. — A new study suggests that a one-time treatment that modulates the composition of a type of immune cell could potentially revitalize the immune systems of the elderly, helping their bodies better react to viral and bacterial threats. The research was carried out... Read More

March 27, 2024
by Dan McCue
Insurers to Expand Access to ‘Navigation Services’ for Cancer Patients

WASHINGTON — Seven of the nation’s largest health insurance companies are expanding access to so-called “navigation services” to help patients... Read More

WASHINGTON — Seven of the nation’s largest health insurance companies are expanding access to so-called “navigation services” to help patients and their families navigate the myriad challenges that might arise during treatment for cancer and other serious illnesses. The insurers involved are Aetna; Blue Cross Blue... Read More

Five Takeaways From the Abortion Pill Case Before US Supreme Court

WASHINGTON (AP) — U.S. Supreme Court justices on Tuesday did not appear ready to limit access to the abortion pill mifepristone,... Read More

WASHINGTON (AP) — U.S. Supreme Court justices on Tuesday did not appear ready to limit access to the abortion pill mifepristone, in a case that could have far-reaching implications for millions of American women and for scores of drugs regulated by the Food and Drug Administration. It's... Read More

Biden and Harris Argue Democrats Will Preserve Health Care and Republicans Would Take It Away

RALEIGH, N.C. (AP) — President Joe Biden and Vice President Kamala Harris on Tuesday promoted their health care agenda in... Read More

RALEIGH, N.C. (AP) — President Joe Biden and Vice President Kamala Harris on Tuesday promoted their health care agenda in the battleground state of North Carolina, arguing that Democrats like themselves would preserve access to care while Republicans would reverse gains made over the past decade... Read More

March 26, 2024
by Tom Ramstack
Supreme Court Skeptical of Ban on Abortion Pill Mifepristone

WASHINGTON — A hearing Tuesday before the Supreme Court indicated a majority of the justices want to maintain women’s access... Read More

WASHINGTON — A hearing Tuesday before the Supreme Court indicated a majority of the justices want to maintain women’s access to the abortion pill mifepristone despite objections from anti-abortion activists. The doctors and organizations who sued argued the Food and Drug Administration was wrong in granting... Read More

March 26, 2024
by Dan McCue
Consumers Warned to Avoid Certain Topical Pain Relief Products 

WASHINGTON — The Food and Drug Administration warned consumers on Tuesday not to use certain over-the-counter pain relief products marketed... Read More

WASHINGTON — The Food and Drug Administration warned consumers on Tuesday not to use certain over-the-counter pain relief products marketed for topical use before, during or after certain cosmetic procedures. The warning came after the agency issued warning letters to six companies for marketing these products... Read More

News From The Well
scroll top